Exosomes from patients with Kras chemoresistant lung cancer patients have been shown to remodel metabolism in a PKM2-dependent manner to maintain lung cancer cell metabolic chemoresistance (Petanidis et al., 2020). Here, PKM is linked to lung cancer.